Medline Inc. announces launch of secondary offering of Class A common stock
Key Highlights
- ➤60,000,000 Class A shares offered by Medline selling stockholders
- ➤Underwriters receive 30-day option for 9,000,000 additional shares
- ➤Medline receives no proceeds from the secondary offering
- ➤Medline and Medline Holdings agree to repurchase $200 million of equity
- ➤Repurchase is priced at the underwriters’ offering price and counts toward buyback program
NORTHFIELD, Ill., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today that certain selling stockholders affiliated with Blackstone Inc., The Carlyle Group Inc. and Hellman & Friedman LLC along with GIC Private Limited and its managed affiliate and a wholly owned subsidiary of the Abu Dhabi Investment Authority (collectively, the “Selling Stockholders”) have commenced an underwritten public offering of 60,000,000 shares of Medline’s Class A common stock (the “Offering”) pursuant to a registration statement filed with the Securities and Exchange Commission (the “SEC”). Additionally, the Selling Stockholders intend to grant the underwriters a 30-day option to purchase up to an additional 9,000,000 shares of Medline’s Class A common stock.
Medline is not selling any shares of Class A common stock in the Offering and will not receive any of the proceeds from the sale.
Get started
Create a free account to read the full story.
